Terashima, Masanori http://orcid.org/0000-0002-2967-8267
,
Iwasaki, Yoshiaki
Mizusawa, Junki
Katayama, Hiroshi
Nakamura, Kenichi
Katai, Hitoshi
Yoshikawa, Takaki
Ito, Yuichi
Kaji, Masahide
Kimura, Yutaka
Hirao, Motohiro
Yamada, Makoto
Kurita, Akira
Takagi, Masakazu
Boku, Narikazu
Sano, Takeshi
Sasako, Mitsuru
Funding for this research was provided by:
National Cancer Center Research and Development Fund (23-A-19, 26-A-4, 29-A-3)
Ministry of Health, Labour and Welfare (H19-15, H22-027, H22-23)
Article History
Received: 5 November 2018
Accepted: 15 February 2019
First Online: 2 March 2019
Compliance with ethical standards
:
: Author MT has received personal fees from Taiho, Ono, Chugai, Eli Lilly Japan, Bristol Myers Squib, and Yakult Honsha outside the submitted work. Author MS received personal fees from Taiho, Chugai, Lilly, and Ono outside the submitted work. Author TS has received personal fees from Taiho. Author NB has received grant from Taiho, Ono and Bristol Myer-Squibb, and honorarium form Taiho, Ono, Chugai, Eli Lilly and Bristol Myer-Squibb. Author KN has received personal fees from Bayer, Chugai, Merck, and Eisai outside the submitted work. Author TY has received grants and personal fees from Taiho, Chugai, Yakult, personal fees from Ono, Bristol, Lilly, Terumo, Abbott, Johnson and Johnson, Covidien, Olympus, Nihon Kayaku, Daiichi Sankyo outside the submitted work. Author HK has received personal fees from Johnson & Johnson outside the submitted work.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the 1964 Declaration of Helsinki and later versions.
: Informed consent was obtained from all patients for inclusion in the study.